Quality of Life in Elderly After Aneurysmal Subarachnoid Hemorrhage (SAH)
NCT ID: NCT00692744
Last Updated: 2014-09-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
353 participants
OBSERVATIONAL
2008-10-31
2014-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this age bracket, the single randomized which compared endovascular coiling to microsurgical clipping (ISAT Study) showed that the relative risk of morbidity increased after coiling. Moreover, some prospectives studies about endovascular coiling described favorable outcome in 48% to 63% of patients, complete occlusion in 51% to 69% and a procedural complication rate in 13% to 19%. From prospectives series, the proportion of favorable outcome after microsurgical clipping was estimated around 66% but the procedural complications are few reported. The outcome for patients treated conservatively was catastrophic. Lastly, the hydrocephalus in this age class is common, occurring in 55% of patients.
The study hypothesis is that, in this age class, no difference exists between the 2 obliteration procedures.
An accurate evaluation of result in term of functional disability, quality of life and prognosis predictive factors seems a judicious question.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long-term Prognosis of Emergency Aneurysmal Subarachnoid Hemorrhage
NCT04785976
Multimodality Monitoring Directed Management of Aneurysmal Subarachnoid Haemorrhage
NCT03010709
Prospective Study of Long-term Outcome After Non-aneurysmal Subarachnoid Hemorrhage
NCT02334657
A Multicenter Registry Study of Aneurysmal SAH
NCT03094975
Detailed Clinical and MRI Characteristics in Primary Non-traumatic Convexity Subarachnoid Haemorrhage Elderly Patients.
NCT04825808
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Randomized multicenter trial: 2 randomized arms (clipping and coiling) plus 3 observational prospective arms (clipping, coiling, conservative).
Inclusion time: 48 months. Follow up: 12 months. Monitoring: 6 months. Duration of the trial: 66 months. Major end point: proportion of patients with unfavourable outcome at 12 months (mRS \> 2).
Secondary end point: Quality of life at 12 months (EORTC scale), causes of morbidity (mRS \> 2) and mortality, Dysautonomia according to the ADL and IADL scales.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Randomized microsurgical
After randomization, this group was constituted of patients treated by microsurgical clipping.
No interventions assigned to this group
Randomized endovascular
After randomization, this group was constituted of patients treated by endovascular coiling.
No interventions assigned to this group
Prospective observational microsurgical
The randomization was ethically unsuitable because of the aneurysm predisposed to the microsurgical clipping after discussion into the neurovascular interdisciplinary team.
No interventions assigned to this group
Prospective observational endovascular
The randomization was ethically unsuitable because of the aneurysm morphology predisposed to the endovascular coiling after discussion into the neurovascular interdisciplinary team.
No interventions assigned to this group
Prospective observational conservative
This group was constituted of patients whom no curative treatment of the aneurysm sac could not be proposed.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subarachnoid hemorrhage in grade I-IV of WFNS scale
* Ruptured cerebral aneurysm diagnosed on multislice computed tomography angiography or cerebral angiography
* treatment of subarachnoid hemorrhage
Exclusion Criteria
* Subarachnoid hemorrhage without cerebral aneurysm
* Patients with cerebral dementia, neurologic or psychiatric antecedents
70 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Rouen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
François PROUST, M.D., Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Rouen
Serge BRACARD, M.D., Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Central Hospital, Nancy, France
Guillaume PENCHET, M.D.
Role: STUDY_DIRECTOR
University Hospital, Bordeaux
Evelyne EMERY, M.D.
Role: STUDY_DIRECTOR
University Hospital, Caen
Bernard IRTHUM, M.D.
Role: STUDY_DIRECTOR
Clermont University Hospital
Klaus MOURIER, M.D.
Role: STUDY_DIRECTOR
Centre Hospitalier Universitaire Dijon
Emmanuel GAY, M.D.
Role: STUDY_DIRECTOR
University Hospital, Grenoble
Jean-Paul LEJEUNE, M.D.
Role: STUDY_DIRECTOR
Lille University Hospital
Isabelle PELISSOU, M.D.
Role: STUDY_DIRECTOR
Hospices Civils de Lyon
Pierre Hughes ROCHE, M.D.
Role: STUDY_DIRECTOR
University Hospital, Marseille
Thierry CIVIT, M.D.
Role: STUDY_DIRECTOR
Central Hospital, Nancy, France
Michel LONJON, M.D.
Role: STUDY_DIRECTOR
Nice University Hospital
Philippe DAVID, M.D.
Role: STUDY_DIRECTOR
Paris University Hospital
Benoit BATAILLE, M.D.
Role: STUDY_DIRECTOR
Poitiers University Hospital
Xavier MORANDI, M.D.
Role: STUDY_DIRECTOR
Rennes University Hospital
Jacques LAGUARRIGUE, M.D.
Role: STUDY_DIRECTOR
University Hospital, Toulouse
Romain BILLON-GRAND, M.D.
Role: STUDY_DIRECTOR
Besançon University Hospital
Damien BRESSON, M.D.
Role: STUDY_DIRECTOR
Paris University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
PROUST
Rouen, , France
Rouen University Hospital
Rouen, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Proust F, Gerardin E, Derrey S, Lesveque S, Ramos S, Langlois O, Tollard E, Benichou J, Chassagne P, Clavier E, Freger P. Interdisciplinary treatment of ruptured cerebral aneurysms in elderly patients. J Neurosurg. 2010 Jun;112(6):1200-7. doi: 10.3171/2009.10.JNS08754.
Proust F, Bracard S, Thines L, Leclerc X, Penchet G, Berge J, Vignes JR, Irthum B, Gabrillargues J, Chazal J, Bataille B, Drouinau J, Mourier K, Ricolfi F, Gay E, Bessou P, Lonjon M, Sedat J, David P, Lajaunias P, Morandi X, Gauvrit JY, Pelissou I, Turjman F, Roche PH, Dufour H, Levrier O, Emery E, Courtheoux P, Laguarrigue J, Cognard C, Civit T, Lejeune JP. [Aneurismal subarachnoid hemorrhage in the elderly subject. Should this patient participate in a randomized clinical trial?]. Neurochirurgie. 2010 Feb;56(1):67-72. doi: 10.1016/j.neuchi.2009.11.002. Epub 2010 Jan 8. No abstract available. French.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2007/042/HP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.